Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production

被引:120
作者
Bozec, Aline [1 ]
Bakiri, Latifa [1 ]
Jimenez, Maria [1 ]
Schinke, Thorsten [2 ]
Amling, Michael [2 ]
Wagner, Erwin F. [1 ]
机构
[1] Spanish Natl Canc Ctr, Canc Cell Biol Program, BBVA Fdn, Genes Dev & Dis Grp, E-28029 Madrid, Spain
[2] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany
基金
欧洲研究理事会;
关键词
MOUSE OSTEOCALCIN GENE; OSTEOSARCOMA CELL-LINE; GROWTH-FACTOR-BETA; TRANSGENIC MICE; IN-VITRO; EXPRESSION; PROMOTER; MASS; ADIPOGENESIS; ACTIVATOR;
D O I
10.1083/jcb.201002111
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
T he activator protein-1 (AP-1) transcription factor complex, in particular the Fos proteins, is an important regulator of bone homeostasis. Fra-2 (Fosl2), a Fos-related protein of the AP-1 family, is expressed in bone cells, and newborn mice lacking Fra-2 exhibit defects in chondrocytes and osteoclasts. Here we show that Fra-2-deficient osteoblasts display a differentiation defect both in vivo and in vitro. Moreover, Fra-2-overexpressing mice are osteosclerotic because of increased differentiation of osteoblasts, which appears to be cell autonomous. Importantly, the osteoblast-specific osteocalcin (Oc) gene and collagen1 alpha 2 (col1 alpha 2) are transcriptional targets of Fra-2 in both murine and human bone cells. In addition, Fra-2, Oc, and col1 are expressed in stromal cells of human chondroblastic and osteoblastic osteosarcomas (Os's) as well as during osteoblast differentiation of human Os cell lines. These findings reveal a novel function of Fra-2/AP-1 as a positive regulator of bone and matrix formation in mice and humans.
引用
收藏
页码:1093 / 1106
页数:14
相关论文
共 47 条
[1]   Promoter specificity and biological activity of tethered AP-1 dimers [J].
Bakiri, L ;
Matsuo, K ;
Wisniewska, M ;
Wagner, EF ;
Yaniv, M .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (13) :4952-4964
[2]   Impaired intervertebral disc formation in the absence of Jun [J].
Behrens, A ;
Haigh, J ;
Mechta-Grigoriou, F ;
Nagy, A ;
Yaniv, M ;
Wagner, EF .
DEVELOPMENT, 2003, 130 (01) :103-109
[3]  
Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO
[4]  
2-F
[5]   Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia [J].
Bozec, Aline ;
Bakiri, Latifa ;
Hoebertz, Astrid ;
Eferl, Robert ;
Schilling, Arndt F. ;
Komnenovic, Vukoslav ;
Scheuch, Harald ;
Priemel, Matthias ;
Stewart, Colin L. ;
Amling, Michael ;
Wagner, Erwin F. .
NATURE, 2008, 454 (7201) :221-U61
[6]   In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum [J].
Bruserud, O ;
Tronstad, KJ ;
Berge, R .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (06) :377-384
[7]   REQUIREMENTS FOR TRANSFORMING GROWTH-FACTOR-BETA REGULATION OF THE PRO-ALPHA-2(I) COLLAGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTERS [J].
CHANG, E ;
GOLDBERG, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (09) :4473-4477
[8]   Longevity and lineages: Toward the integrative biology of degenerative diseases in heart, muscle, and bone [J].
Chien, KR ;
Karsenty, G .
CELL, 2005, 120 (04) :533-544
[9]   An AP-1 binding sequence is essential for regulation of the human alpha 2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta [J].
Chung, KY ;
Agarwal, A ;
Uitto, J ;
Mauviel, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) :3272-3278
[10]   JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms [J].
David, JP ;
Sabapathy, K ;
Hoffmann, O ;
Idarraga, MH ;
Wagner, EF .
JOURNAL OF CELL SCIENCE, 2002, 115 (22) :4317-4325